Roger Connor
Chairman at International Federation of Pharmaceutical Manufacturers
Net worth: 4 M $ as of 2024-02-28
Profile
Roger Connor is on the board of Beecham SA, GlaxoSmithKline Consumer Healthcare Pte Ltd.
and Global Alliance on Vaccines & Immunization and Chairman of International Federation of Pharmaceutical Manufacturers.
In the past he was President at GSK Vaccines and President-Vaccines & Global Health at GSK Plc.
He received an undergraduate degree from Queen's University of Belfast and a graduate degree from the University of Cambridge.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GSK PLC
0.00% | 2023-01-11 | 176,108 ( 0.00% ) | 4 M $ | 2024-02-28 |
Roger Connor active positions
Companies | Position | Start |
---|---|---|
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The private company is based in Singapore, Singapore. | Director/Board Member | 2017-03-31 |
Beecham SA
Beecham SA Pharmaceuticals: MajorHealth Technology Founded in 1955, Beecham SA is a Belgian pharmaceutical company that manufactures drugs. The private company is based in Wavre, Belgium and is a part of GSK Plc. | Director/Board Member | 2020-06-18 |
Global Alliance on Vaccines & Immunization
Global Alliance on Vaccines & Immunization Medical/Nursing ServicesHealth Services Global Alliance on Vaccines & Immunization (Gavi) is an international organization that was established in 2000. Gavi's headquarters are located in Geneva, Switzerland, and it operates in over 70 countries worldwide. The organization's main objective is to enhance access to new and underused vaccines for children residing in the poorest countries worldwide. | Director/Board Member | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is an organization that represents the innovative pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer is important in bridging research and development gaps, increasing the availability of vaccines and medicines, and stimulating investment in key industrial areas. The CEO of the company is Thomas Cueni. | Chairman | - |
Former positions of Roger Connor
Companies | Position | End |
---|---|---|
GSK PLC | Corporate Officer/Principal | 2022-11-30 |
GSK Vaccines | President | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | - |
Training of Roger Connor
University of Cambridge | Graduate Degree |
Queen's University of Belfast | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GSK PLC | Health Technology |
Private companies | 6 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is an organization that represents the innovative pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer is important in bridging research and development gaps, increasing the availability of vaccines and medicines, and stimulating investment in key industrial areas. The CEO of the company is Thomas Cueni. | Health Technology |
Beecham SA
Beecham SA Pharmaceuticals: MajorHealth Technology Founded in 1955, Beecham SA is a Belgian pharmaceutical company that manufactures drugs. The private company is based in Wavre, Belgium and is a part of GSK Plc. | Health Technology |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The private company is based in Singapore, Singapore. | Consumer Non-Durables |
Global Alliance on Vaccines & Immunization
Global Alliance on Vaccines & Immunization Medical/Nursing ServicesHealth Services Global Alliance on Vaccines & Immunization (Gavi) is an international organization that was established in 2000. Gavi's headquarters are located in Geneva, Switzerland, and it operates in over 70 countries worldwide. The organization's main objective is to enhance access to new and underused vaccines for children residing in the poorest countries worldwide. | Health Services |
GSK Vaccines |